If you’ve started Semaglutide and noticed more hair in your brush or shower drain, you’re not imagining it. Some patients do experience hair thinning while on treatment — but the cause is more nuanced than “the medication is doing this to me.” Here’s the short answer: Semaglutide itself doesn’t appear to damage hair follicles. What…
If you’ve started Semaglutide and noticed more hair in your brush or shower drain, you’re not imagining it. Some patients do experience hair thinning while on treatment — but the cause is more nuanced than “the medication is doing this to me.”
Here’s the short answer: Semaglutide itself doesn’t appear to damage hair follicles. What most patients experience is telogen effluvium — a temporary shedding pattern triggered by rapid weight loss, not a direct pharmacological side effect of the drug. Below, we’ll walk through what the FDA data actually shows, whether Ozempic® causes hair loss the same way Wegovy® does, and what you can do to protect your hair while reaching your weight-loss goals.
Yes — semaglutide side effects can include hair loss, and the data is more specific than most people realize. So can semaglutide cause hair loss on its own, separate from weight loss? According to the FDA prescribing information for Wegovy® (semaglutide 2.4 mg), hair loss was reported in 3% of patients treated with Wegovy®, compared to 1% of patients on placebo, across clinical trials involving more than 2,100 adults with obesity or overweight.
That’s a real, measurable difference — but it’s worth putting in context. Wegovy® is approved at a higher maintenance dose (2.4 mg weekly) than Ozempic®, which is FDA-approved for type 2 diabetes and typically maintained at lower doses. Hair loss is not currently listed as a reported adverse reaction in Ozempic®’s own prescribing information. That doesn’t mean it can’t happen on Ozempic® — since both medications share the same active ingredient — but the clinical trial data specific to hair loss comes from the Wegovy® program, not Ozempic®’s.
Here’s the part that surprises most patients: Semaglutide isn’t believed to attack hair follicles directly. The shedding pattern most people describe is consistent with telogen effluvium, a well-documented type of hair loss that happens when the body is under physical stress — including the stress of losing weight quickly.
Normally, most of your scalp hair sits in a growth phase at any given time, with only a small percentage resting or shedding. When the body experiences a significant physiological stressor — rapid weight loss, a sudden drop in calorie intake, illness, or major nutritional shifts — a larger share of hairs can shift into that resting phase at once. A few months later, those hairs fall out together, which is why the shedding often feels sudden even though the trigger happened earlier.
At CardioMender, MD’s Semaglutide program, dosing is escalated gradually — starting at 0.25 mg and building toward the 2.4 mg maintenance dose over about four months. It’s worth noting that most patients don’t reach their fastest rate of weight loss until they’re on a higher, maintenance-level dose, which is also when telogen effluvium is most likely to show up if it’s going to.
Does Ozempic® cause hair loss? It’s one of the most common questions patients ask, and much of the public conversation lumps Ozempic® and hair loss together with Wegovy® data — but the two deserve to be looked at separately, since they’re approved at different doses for different conditions.
A 2025 letter published in the Journal of Cosmetic Dermatology by dermatologist Diala Haykal (PMID: 40087997) drew attention to a growing body of literature connecting GLP-1 receptor agonists, including Semaglutide, to reported cases of alopecia. It’s worth being precise about what this letter is: a commentary summarizing several other studies and calling for more rigorous research, rather than a study that generated new data of its own.
One of the more detailed pieces of real-world evidence comes from a 2025 retrospective cohort study posted as a preprint on medRxiv (meaning it has not yet completed peer review) that followed nearly 2,000 Semaglutide users compared to users of a different weight-loss medication. After adjusting for other health factors, the researchers found an adjusted hazard ratio for hair loss of 2.08 in women taking Semaglutide (95% confidence interval: 1.17–3.72) — a statistically meaningful increase in risk. The hazard ratios calculated for men (0.86) and for the group as a whole (1.52) were not statistically significant, meaning the data doesn’t currently support a clear increased risk for those groups.
Taken together, the clinical trial data (the 3% vs. 1% Wegovy® figures) and this early real-world cohort data point in a similar direction: hair loss is an uncommon but real occurrence, and it appears more clearly documented in women than in men so far.
For the large majority of patients, semaglutide hair loss is reversible, and it doesn’t destroy the hair follicle — it just interrupts the growth cycle. Once the follicle isn’t being pushed by ongoing rapid weight loss or nutritional stress, it typically returns to its normal growth pattern.
In practice, this means shedding tends to appear a few months after a period of fast weight loss, and regrowth tends to follow a few months after weight and nutrition stabilize. We’d rather not hand you an exact week-by-week countdown here, since the honest answer is that recovery timelines vary meaningfully from person to person depending on nutrition, the pace of weight loss, and individual hair biology.
If you’re wondering how to stop hair loss from Ozempic® or Wegovy® — including how to stop hair loss from Ozempic® specifically if you’re a woman, since the research above suggests women may be more affected — the good news is that most of the meaningful prevention happens around how the weight loss itself is managed, since the shedding is tied to the stress of rapid weight loss and nutritional shifts rather than the medication acting directly on hair follicles:
Patients on CardioMender, MD’s program also have access to Vitamin B12 and lipotropic support, which some patients use alongside their nutrition plan — always in coordination with their provider rather than as a self-directed add-on.
Physician-supervised care exists precisely for situations like this one. A gradual, monitored dose escalation, regular bloodwork, and a nutrition plan built around adequate protein intake all work together to reduce the odds of the kind of physiological stress that triggers telogen effluvium in the first place.
If you’re already noticing more shedding than usual, that’s worth a conversation with your provider rather than a reason to stop treatment on your own — there may be a simple nutritional gap behind it, or it may simply be your body’s normal response to meaningful weight loss.
Ready to start Semaglutide treatment with full medical oversight, or want to talk through hair health concerns with our clinical team? Schedule your consultation at CardioMender, MD in Pembroke Pines, FL, or call (954) 799-6439.
Does Ozempic® cause hair loss the same way Wegovy® does?
Not exactly. The 3% vs. 1% hair loss data comes from Wegovy®’s FDA-reviewed clinical trials at its 2.4 mg maintenance dose (see the FDA data above). Ozempic®, which is typically prescribed at lower doses for type 2 diabetes, doesn’t list hair loss in its own prescribing information, though anecdotal reports exist since both medications share the same active ingredient.
Is hair loss from Semaglutide the same for men and women?
Early research on semaglutide and hair loss in women suggests they may be more affected than men. The 2025 preprint cohort study discussed above found a statistically significant increased hazard ratio for hair loss in women (2.08) but not in men, though this research hasn’t yet completed peer review and more study is needed.
Should I stop taking Semaglutide if I notice hair loss?
Don’t make that call on your own. Talk with your prescribing provider first — they can check for nutritional deficiencies, review your dosing pace, and help you decide whether any changes are needed. Stopping a medically supervised treatment without guidance isn’t recommended.
Is Semaglutide hair loss different from Tirzepatide hair loss?
When people compare semaglutide vs. tirzepatide hair loss, the underlying mechanism looks similar — both are linked to telogen effluvium from rapid weight loss rather than a direct effect on hair follicles. If you’re curious about the Tirzepatide side specifically, we cover it in Does Tirzepatide Cause Hair Loss?
Our physician-supervised weight loss and aesthetic programs are designed around your unique body, goals, and lifestyle.
